Akso Health Group current report, Q4 FY2018

Business Context and Reporting Period

This Form 6-K filing is submitted by Hexindai Inc., a foreign private issuer, for the month of October 2018. The registrant's principal executive office is located in Beijing, People's Republic of China. The report was signed by Zhang Qisen (Johnson), Chief Financial Officer, on October 16, 2018. The filing primarily serves to distribute a press release (Exhibit 99.1) and does not contain detailed financial statements within the provided text.

Key Financial Metrics

The provided filing text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a cover sheet for an external press release rather than a financial statement itself.

Material Changes

No material changes versus the prior comparable period are detailed in the provided text. The filing references a press release for substantive updates but does not summarize those changes directly.

Guidance, Outlook, and Risks

The filing text does not provide management commentary, guidance, outlook, risks, contingencies, or details on unusual items. Investors are directed to the attached press release (Exhibit 99.1) for such information.

Investor Verification Checklist

  • Verify the content of the attached Press Release (Exhibit 99.1) for specific operational or financial updates.
  • Confirm the identity of the registrant as Hexindai Inc., noting the discrepancy with the user-provided company name "Akso Health Group."
  • Review the full Form 20-F for comprehensive financial data, as this Form 6-K is a current report of material events rather than a periodic financial report.